Perelman School of Medicine

Audio: 8 Reasons Why We Love Science Even More

December 12, 2014

Maria Geffen of the Perelman School of Medicine talks about sound and meaning.

How the ‘Psychological Drama’ Taught Peter Lorre How to Act

December 12, 2014

Jonathan Moreno of the Perelman School of Medicine and the School or Arts & Sciences writes about actor Peter Lorre.

Article Source: Psychology Today

Genetic Testing for Alzheimer’s – Without Revealing the Results

December 12, 2014

Reed Pyeritz of the Perelman School of Medicine comments on genetic testing for diseases.

Article Source: Wall Street Journal

Long Radiation Treatments Called Unnecessary in Many Breast Cancer Cases

December 10, 2014

New research about breast cancer treatment from the Perelman School of Medicine’s Justin Bekelman and Ezekiel Emanuel, also of the Whar

Article Source: New York Times
facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653December 10, 2014

Penn Study: Majority of Women with Early-Stage Breast Cancer in U.S. Receive Unnecessarily Long Courses of Radiation

Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicineresearchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660December 10, 2014

Simeprevir-Based Therapy Offers Alternative Treatment of Hepatitis C Says Penn Study

blurb: 
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.

Cutting Docs-in-Training Hours Hasn't Improved Patient Care: Studies

December 9, 2014

Perelman School of Medicine’s Mitesh Patel is quoted about a Penn study on doctor fatigue and patient care.

Article Source: Philadelphia Inquirer

Special K, a Hallucinogen, Raises Hopes and Concerns as a Treatment for Depression

December 9, 2014

Dominic A. Sisti of the Perelman School of Medicine shares his opinion on using hallucinogenic drugs to treat depression.

Article Source: New York Times
facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659December 8, 2014

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

blurb: 
Findings Include Response Rates Over 90 Percent in Pediatric Acute Lymphoblastic Leukemia, and First Results of Non-Hodgkin Lymphoma Trial

The latest results of clinical trials of more than 125 patients testing an investigational personalized cellular therapy known as CTL019 will be presented by a University of Pennsylvania research team at the 56th American Society of Hematology Annual Meeting and Exposition.

Audio: Penn Scientists Find Way to Prevent Memory Loss After Sleep Deprivation

December 8, 2014
Robbert Havekes of the Perelman School of Medicine comments on how lack o
Article Source: Newsworks